Melvin L. Samuels

3.4k total citations · 1 hit paper
44 papers, 2.5k citations indexed

About

Melvin L. Samuels is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Melvin L. Samuels has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Melvin L. Samuels's work include Testicular diseases and treatments (18 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Sarcoma Diagnosis and Treatment (8 papers). Melvin L. Samuels is often cited by papers focused on Testicular diseases and treatments (18 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Sarcoma Diagnosis and Treatment (8 papers). Melvin L. Samuels collaborates with scholars based in United States, Vietnam and Spain. Melvin L. Samuels's co-authors include Douglas E. Johnson, Christopher J. Logothetis, Antonio Trindade, Paul Y. Holoye, David A. Swanson, Victor J. Lanzotti, Avishay Sella, Jae Y. Ro, Alberto G. Ayala and Terry L. Smith and has published in prestigious journals such as JAMA, Cancer and Radiology.

In The Last Decade

Melvin L. Samuels

43 papers receiving 2.3k citations

Hit Papers

The growing teratoma synd... 1982 2026 1996 2011 1982 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melvin L. Samuels United States 28 1.5k 1.1k 614 483 346 44 2.5k
Michael J. Morse United States 19 2.4k 1.7× 889 0.8× 664 1.1× 330 0.7× 220 0.6× 32 2.9k
M.H. Cullen United Kingdom 23 933 0.6× 936 0.8× 1.2k 2.0× 427 0.9× 282 0.8× 61 2.6k
F.K. Mostofi United States 27 1.2k 0.8× 1.4k 1.2× 288 0.5× 705 1.5× 231 0.7× 48 2.6k
Luigi Piva Italy 29 1.8k 1.3× 928 0.8× 389 0.6× 651 1.3× 294 0.8× 130 2.6k
F Flamant France 33 933 0.6× 1.6k 1.4× 774 1.3× 484 1.0× 257 0.7× 96 2.9k
H.W. Herr United States 36 3.7k 2.6× 1.1k 1.0× 826 1.3× 895 1.9× 396 1.1× 82 4.4k
J. Nicholls United Kingdom 17 1.4k 1.0× 497 0.4× 245 0.4× 397 0.8× 483 1.4× 30 1.8k
Giorgio Pizzocaro Italy 33 3.3k 2.3× 902 0.8× 438 0.7× 790 1.6× 608 1.8× 133 4.0k
Jillian R. Mann United Kingdom 27 905 0.6× 361 0.3× 390 0.6× 447 0.9× 155 0.4× 82 2.2k
A. Gerl Germany 32 2.2k 1.5× 745 0.7× 213 0.3× 457 0.9× 544 1.6× 74 2.7k

Countries citing papers authored by Melvin L. Samuels

Since Specialization
Citations

This map shows the geographic impact of Melvin L. Samuels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin L. Samuels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin L. Samuels more than expected).

Fields of papers citing papers by Melvin L. Samuels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin L. Samuels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin L. Samuels. The network helps show where Melvin L. Samuels may publish in the future.

Co-authorship network of co-authors of Melvin L. Samuels

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin L. Samuels. A scholar is included among the top collaborators of Melvin L. Samuels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin L. Samuels. Melvin L. Samuels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Clayton, et al.. (1988). The Correlation of Vinblastine Pharmacokinetics to Toxicity in Testicular Cancer Patients. The Journal of Clinical Pharmacology. 28(8). 714–718. 12 indexed citations
2.
Ro, Jae Y., Alberto G. Ayala, Avishay Sella, Melvin L. Samuels, & David A. Swanson. (1987). Sarcomatoid renal cell carcinoma: Clinicopathologic. A study of 42 cases. Cancer. 59(3). 516–526. 194 indexed citations
3.
Dexeus, Francisco H., Christopher J. Logothetis, Melvin L. Samuels, Alberto G. Ayala, & Elizabeth Hossan. (1987). Complete Responses in Metastatic Transitional Cell Carcinoma of the Prostate With Cisplatin Regimens. The Journal of Urology. 137(1). 122–125. 12 indexed citations
4.
Logothetis, Christopher J., Melvin L. Samuels, Sheryl Ogden, et al.. (1985). Cyclophosphamide, Doxorubicin and Cisplatin Chemotherapy for Patients with Locally Advanced Urothelial Tumors with or without Nodal Metastases. The Journal of Urology. 134(3). 460–464. 67 indexed citations
5.
Rusch, Valerie W., Christopher J. Logothetis, & Melvin L. Samuels. (1984). Endodermal Sinus Tumor of the Mediastinum. CHEST Journal. 86(5). 745–747. 5 indexed citations
6.
Stewart, David J., Robert S. Benjamin, Stuart O. Zimmerman, et al.. (1983). Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).. PubMed. 43(2). 917–20. 114 indexed citations
7.
Bracken, R. Bruce, Douglas E. Johnson, O.H. Frazier, et al.. (1983). The Role of Surgery Following Chemotherapy in Stage III Germ Cell Neoplasms. The Journal of Urology. 129(1). 39–43. 37 indexed citations
8.
Logothetis, Christopher J., Melvin L. Samuels, Antonio Trindade, & Douglas E. Johnson. (1982). The growing teratoma syndrome. Cancer. 50(8). 1629–1635. 373 indexed citations breakdown →
9.
Liu, Frank, Herbert A. Fritsche, José M. Trujillo, & Melvin L. Samuels. (1982). Serum Lactate Dehydrogenase Isoenzyme 1 in Patients with Advanced Testicular Cancer. American Journal of Clinical Pathology. 78(2). 178–183. 17 indexed citations
10.
Nogeire, Christopher, et al.. (1981). 5-Fluorouracil, adriamycin, and mitomycin-C (Hi-FAM) chemotherapy for adenocarcinoma of the lung. Cancer. 48(1). 21–25. 9 indexed citations
11.
Samuels, Melvin L. & Douglas E. Johnson. (1980). Adjuvant Therapy of Testis Cancer: The Role of Vinblastine and Bleomycin. The Journal of Urology. 124(3). 369–371. 21 indexed citations
12.
Babaian, Richard J., et al.. (1980). Mixed mesodermal tumors of urinary bladder. Urology. 15(3). 261–264. 11 indexed citations
13.
Spitzer, Gary, Karel A. Dicke, D. S. Verma, et al.. (1980). High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors. Cancer. 45(12). 3075–3085. 99 indexed citations
14.
Chan, Rafael C., Wataru W. Sutow, Robert D. Lindberg, et al.. (1978). Management and results of localized Ewing's sarcoma. International Journal of Radiation Oncology*Biology*Physics. 4. 57–57. 2 indexed citations
15.
Holoye, Paul Y., Melvin L. Samuels, Terry Smith, & Joseph G. Sinkovics. (1978). Chemoimmunotherapy of small cell bronchogenic carcinoma. Cancer. 42(1). 34–40. 25 indexed citations
16.
Samuels, Melvin L., Douglas E. Johnson, Paul Y. Holoye, & Victor J. Lanzotti. (1976). Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 235(11). 1117–20. 115 indexed citations
17.
Johnson, Douglas E., et al.. (1975). Is Nephrectomy Justified in Patients with Metastatic Renal Carcinoma?. The Journal of Urology. 114(1). 27–29. 109 indexed citations
18.
Fernández, C. Hernández, Robert D. Lindberg, Wataru W. Sutow, & Melvin L. Samuels. (1974). Localized ewing's sarcoma—treatment and results. Cancer. 34(1). 143–148. 77 indexed citations
19.
Samuels, Melvin L., et al.. (1966). Research Abstracts. AV communication review. 14(1). 145–152. 1 indexed citations
20.
Samuels, Melvin L., et al.. (1958). Needle biopsy of pleura. An evaluation in patients with pleural efusion of neoplastic origin. Cancer. 11(5). 980–983. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026